Blueprint Medicines Corporation BPMC
129.46 0.00 0.00%
At close · Jul 18
52-week range unavailable
- YTD
- +48.43%
- 1 year
- +13.20%
- Open
- 129.46
- Prev close
- 129.46
- Mkt cap
- 8.37B
- Vol
- 2.98M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 129.46
- High
- 129.46
- Forward P/E
- -137.72
- Beta
- 0.83
- Short ratio
- 0.62
- Inst. own
- 109.19%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 120.02
- 200-d avg
- 100.22
- 1y target
- 130.29
MAX chart
Chart tools
Chart is warming up
The all-time price history for BPMC has not been loaded yet. Try again in a moment.
Altman Z-Score
3.68 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -81.5×
P/S 10.8×
P/B 18.4×
P/FCF -27.8×
EV/EBITDA 304×
EV/Sales 11.5×
FCF Yield -3.6%
Gross Margin 96.0%
Operating Margin -41.7%
Net Margin -13.2%
ROE -22.5%
ROIC -21.7%
ROA -5.7%
Revenue 104.0%
Operating Income 56.4%
EPS (diluted) 87.2%
Free Cash Flow 56.5%
Current Ratio 2.8×
Quick Ratio 2.8×
Debt / Equity 1.6×
Net Debt / EBITDA 19.1×
Interest Coverage -3.1×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31